Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5351
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
| $157K | ﹤0.01% |
11,535
-3,924
| -25% | -$52.9K |
2013 Q3
16 quarters
|
|
5352
Invesco DB US Dollar Index Bearish Fund
UDN
$102M
| $156K | ﹤0.01% |
6,995
-1,838
| -21% | -$40.9K |
2013 Q2
17 quarters
|
|
|
MSF
5353
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
| $155K | ﹤0.01% |
8,938
+1,175
| +15% | +$19.9K |
2013 Q2
17 quarters
|
|
5354
Vitamin Cottage Natural Grocers
NGVC
$705M
| $154K | ﹤0.01% |
27,681
+3,095
| +13% | +$20.7K |
2013 Q2
17 quarters
|
|
|
RALS
5355
DELISTED
ProShares RAFI Long/Short
RALS
| $154K | ﹤0.01% |
4,113
+795
| +24% | +$29.9K |
2013 Q2
17 quarters
|
|
5356
Digital Turbine
APPS
$1.28B
| $153K | ﹤0.01% |
101,460
+100,093
| +7,322% | +$118K |
2014 Q1
14 quarters
|
|
5357
Valhi
VHI
$415M
| $153K | ﹤0.01% |
5,231
-4,420
| -46% | -$142K |
2013 Q2
17 quarters
|
|
|
DXPS
5358
DELISTED
WisdomTree United Kingdom Hedged Equity Fund
DXPS
| $153K | ﹤0.01% |
6,435
-1,531
| -19% | -$37K |
2013 Q4
15 quarters
|
|
5359
Western Copper and Gold
WRN
$414M
| $152K | ﹤0.01% |
+130,900
| New | +$155K |
2017 Q3
0 quarters
|
|
5360
aTyr Pharma
ATYR
$18M
| $150K | ﹤0.01% |
2,116
-12
| -0.6% | -$556 |
2015 Q2
9 quarters
|
|
|
CTIC
5361
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $150K | ﹤0.01% |
47,115
+8,936
| +23% | +$29.8K |
2013 Q2
17 quarters
|
|
5362
Nature's Sunshine
NATR
$222M
| $148K | ﹤0.01% |
14,514
-6,455
| -31% | -$73.2K |
2013 Q2
17 quarters
|
|
5363
DELISTED
Adams Resources & Energy Inc
AE
| $148K | ﹤0.01% |
3,558
+968
| +37% | +$36.4K |
2016 Q3
4 quarters
|
|
5364
Oramed Pharmaceuticals
ORMP
$174M
| $147K | ﹤0.01% |
14,766
+2,131
| +17% | +$18.4K |
2013 Q4
15 quarters
|
|
|
AMOV
5365
DELISTED
America Movil SAB de CV
AMOV
| $147K | ﹤0.01% |
8,540
+510
| +6% | +$8.76K |
2013 Q4
15 quarters
|
|
|
CYOU
5366
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $147K | ﹤0.01% |
3,711
-37,902
| -91% | -$1.53M |
2013 Q2
17 quarters
|
|
5367
iShares MSCI China Small-Cap ETF
ECNS
$60.3M
| $145K | ﹤0.01% |
2,839
-500
| -15% | -$24K |
2013 Q2
17 quarters
|
|
5368
Watsco Inc Class B
WSO.B
$11.9B
| $145K | ﹤0.01% |
900
| – | – |
2013 Q4
15 quarters
|
|
|
NJV
5369
DELISTED
Nuveen New Jersey Municipal Value Fund Common shares of beneficial interest
NJV
| $145K | ﹤0.01% |
9,734
-804
| -8% | -$12K |
2014 Q1
14 quarters
|
|
|
RNWK
5370
DELISTED
RealNetworks Inc
RNWK
| $145K | ﹤0.01% |
30,369
+8,460
| +39% | +$36.5K |
2013 Q2
17 quarters
|
|
5371
Alico
ALCO
$282M
| $143K | ﹤0.01% |
4,193
+1,128
| +37% | +$35.8K |
2013 Q4
15 quarters
|
|
5372
Matinas BioPharma
MTNB
$2.37M
| $143K | ﹤0.01% |
145
+78
| +116% | +$78.1K |
2017 Q1
2 quarters
|
|
5373
Urban One Class D
UONEK
$17.7M
| $143K | ﹤0.01% |
8,654
-5,134
| -37% | -$93.2K |
2013 Q2
17 quarters
|
|
5374
DELISTED
MANNING & NAPIER, INC.
MN
| $143K | ﹤0.01% |
36,019
-33,330
| -48% | -$127K |
2013 Q2
17 quarters
|
|
5375
Cumberland Pharmaceuticals
CPIX
$113M
| $142K | ﹤0.01% |
20,053
-965
| -5% | -$6.67K |
2013 Q2
17 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.